Please assess the completion status of the following clinical trial:

Trial Title: Parecoxib for Treatment of Catheter Related Bladder Discomfort

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult (\>/=18)~2. Male or female~3. Undergoing catheterization after transurethral resection of bladder tumor (TURBT)~4. Under spinal anesthesia~5. Subject is American Society of Anesthesiologists (ASA) physical status 1 or 2.~Exclusion Criteria:~1. Patient who disagrees to participate this investigation~2. Patient with severe cardiovascular disease~3. Patient with small-sized foley catheter (less than 18 Fr.)~4. Patinets with bladder outflow obstruction~5. Patient with overactive bladder (frequency \>3 times,in the night or \>8 times in 24 h)~6. Patients with chronic renal failure~7. Patient with morbid obesity~8. Patient with medications for chronic pain~9. Patient with disturbance of the central nervous system

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Parecoxib (Type: EXPERIMENTAL): 40 mg of intravenous parecoxib (DYNASTAT )30 min before surgery
- Placebo (Type: PLACEBO_COMPARATOR): An equal volume of saline

Based on this trial design, predict the completion outcome and termination type (if applicable).